Status:
COMPLETED
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Asthma
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Spe...
Detailed Description
Asthma is a serious lung condition that is the leading cause of long-term illness in children. Many common household substances can trigger or worsen an asthma attack. It is important for people to re...
Eligibility Criteria
Inclusion
- House dust mite-induced allergic rhinitis/mild intermittent asthma
Exclusion
- Use of previous allergy immunotherapy for house dust mite asthma
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00200850
Start Date
January 1 2006
End Date
October 1 2008
Last Update
June 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Medical School
Madison, Wisconsin, United States, 53706